#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ocular lymphoma Follicular lymphoma Nephrotic syndrome Hereditary optic atrophy Non-Hodgkin's lymphoma unspecified histology indolent Prolymphocytic leukaemia Adult T-cell lymphoma/leukaemia refractory Neuroendocrine cell hyperplasia of infancy Hereditary ataxia Wolfram syndrome Anti-glomerular basement membrane disease Chronic lymphocytic leukaemia Small cell lung cancer extensive stage B-cell type acute leukaemia Hereditary haemorrhagic telangiectasia More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Diagnostics Propionic acidaemia – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Short-bowel syndrome Hereditary optic atrophy – Basic Information Amyotrophic lateral sclerosis – Trials in Disease Medulloblastoma recurrent – Treatment Lennox-Gastaut syndrome – Treatment Netherton’s syndrome – Life with Disease Brain stem glioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Daptomycin 2,4 DICHLOROBENZYL ALCOHOL Treg02 AMLENETUG Brodalumab NADOFARAGENE FIRADENOVEC Hydrochlorothiazide Rhh646 F510/08 Lactic Acid SODIUM FUSIDATE Deferoxamine Human Mesenchymal Stem Cells Pseudoephedrine Hydrochloride Azd4831 Sodium Zirconium Cyclosilicate Bimatoprost Dried Ferrous Sulfate Insulin Human (Rdna) Pilocarpine Nitrate More therapies…

    Learn about Your Condition

    Uterine cancer Ear discomfort Notalgia paraesthetica Juvenile idiopathic arthritis Carcinoid tumour pulmonary Renal cancer Hyperkalaemia Breast angiosarcoma Microvillous inclusion disease Infertility Abdominal wall pain EGFR gene mutation Neurofibrosarcoma Breast cancer male Epithelioid sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Breast cancer male
    • Breast cancer recurrent
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Ireland Spain

  • Study on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Olaparib
    • Durvalumab
    • Infliximab
    Belgium Estonia Germany Greece Hungary Lithuania +2

  • Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

    Not recruiting

    3 1
    Investigated Drugs:
    • Lanifibranor
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study of Atezolizumab Treatment Before Surgery in Patients with Bladder Cancer or Upper Urinary Tract Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Atezolizumab
    France Spain

  • Study of Bempedoic Acid for Children Aged 6-17 with Familial Hypercholesterolemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Bempedoic Acid
    Denmark Germany The Netherlands Spain

  • Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer recurrent
    Investigated Drugs:
    • Cln-081
    Italy The Netherlands Spain

  • Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Simvastatin
    • Lactose Monohydrate
    Spain

  • Study of Elafibranor in Adults with Primary Biliary Cholangitis Who Don’t Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment

    Not recruiting

    3 1
    Investigated Drugs:
    • Elafibranor
    Czechia France Germany Italy Poland Romania +1

  • Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Fipaxalparant
    Austria France Germany Greece Italy Poland +3

  • Study on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Etrumadenant
    • Quemliclustat
    • Zimberelimab
    France Italy Spain
Previous Page
1 … 15 16 17 18 19 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!